The Selective Serotonin 2A Receptor Antagonist Sarpogrelate Prevents Cardiac Hypertrophy and Systolic Dysfunction via Inhibition of the ERK1/2–GATA4 Signaling Pathway
Kana Shimizu(Waseda University), Tatsuya Morimoto(Toho University)
Cited by 10
Related Papers
The Synthetic Curcumin Analogue GO-Y030 Effectively Suppresses the Development of Pressure Overload-induced Heart Failure in Mice
|Scientific Reports|2020|47
Fibroblast-specific PRMT5 deficiency suppresses cardiac fibrosis and left ventricular dysfunction in male mice
|Nature Communications|2024|27
Multimerization of the GATA4 transcription factor regulates transcriptional activity and cardiomyocyte hypertrophic response
|International Journal of Biological Sciences|2022|21